Is increased atherogenic index of plasma (AIP) associated with worse cardiovascular outcomes in patients with coronary artery disease?
Increased atherogenic index of plasma serves as an independent prognostic biomarker for cardiovascular outcomes in patients with coronary artery disease.
The results of this study demonstrated that increased AIP is an independent prognostic factors in patients with CAD. Further research is warranted to elucidate the potential development of targeted interventions to modify AIP levels and improve patient outcomes.
Rad et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: